Global Peripheral Arterial Disease (PAD) Therapeutics Market Research Report 2024(Status and Outlook)

Global Peripheral Arterial Disease (PAD) Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.

The Global Peripheral Arterial Disease (PAD) Therapeutics Market Size was estimated at USD 3124.06 million in 2023 and is projected to reach USD 4258.82 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.

This report provides a deep insight into the global Peripheral Arterial Disease (PAD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Arterial Disease (PAD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Arterial Disease (PAD) Therapeutics market in any manner.

Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca Plc. (UK)

Bayer HealthCare Pharmaceuticals (Germany)

Bristol-Myers Squibb Company (US)

Merck & Co., Inc. (US)

Proteon Therapeutics, Inc. (US)

Sanofi S.A. (France)

Symic Bio, Inc. (US)

TheraVasc Inc. (US)

AnGes MG, Inc. (Japan)

Athersys, Inc. (US)

Betagenon AB (Sweden)

miRagen Therapeutics, Inc. (US)

Multi Gene Vascular Systems Ltd (Israel)

ViroMed Co. Ltd. (Korea)

Market Segmentation (by Type)

Anti-Platelet Drugs

Dual Antiplatelet Therapy Drugs

Others

Market Segmentation (by Application)

Hospitals

Clinics

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Peripheral Arterial Disease (PAD) Therapeutics Market

Overview of the regional outlook of the Peripheral Arterial Disease (PAD) Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Arterial Disease (PAD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peripheral Arterial Disease (PAD) Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Landscape
3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.6.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peripheral Arterial Disease (PAD) Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peripheral Arterial Disease (PAD) Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2019-2024)
7 Peripheral Arterial Disease (PAD) Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
8 Peripheral Arterial Disease (PAD) Therapeutics Market Segmentation by Region
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca Plc. (UK)
9.1.1 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.1.4 AstraZeneca Plc. (UK) Business Overview
9.1.5 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.1.6 AstraZeneca Plc. (UK) Recent Developments
9.2 Bayer HealthCare Pharmaceuticals (Germany)
9.2.1 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
9.2.5 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
9.3 Bristol-Myers Squibb Company (US)
9.3.1 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.3.5 Bristol-Myers Squibb Company (US) Business Overview
9.3.6 Bristol-Myers Squibb Company (US) Recent Developments
9.4 Merck and Co., Inc. (US)
9.4.1 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.4.2 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.4.3 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.4.4 Merck and Co., Inc. (US) Business Overview
9.4.5 Merck and Co., Inc. (US) Recent Developments
9.5 Proteon Therapeutics, Inc. (US)
9.5.1 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.5.4 Proteon Therapeutics, Inc. (US) Business Overview
9.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
9.6 Sanofi S.A. (France)
9.6.1 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.6.4 Sanofi S.A. (France) Business Overview
9.6.5 Sanofi S.A. (France) Recent Developments
9.7 Symic Bio, Inc. (US)
9.7.1 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.7.4 Symic Bio, Inc. (US) Business Overview
9.7.5 Symic Bio, Inc. (US) Recent Developments
9.8 TheraVasc Inc. (US)
9.8.1 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.8.4 TheraVasc Inc. (US) Business Overview
9.8.5 TheraVasc Inc. (US) Recent Developments
9.9 AnGes MG, Inc. (Japan)
9.9.1 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.9.4 AnGes MG, Inc. (Japan) Business Overview
9.9.5 AnGes MG, Inc. (Japan) Recent Developments
9.10 Athersys, Inc. (US)
9.10.1 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.10.4 Athersys, Inc. (US) Business Overview
9.10.5 Athersys, Inc. (US) Recent Developments
9.11 Betagenon AB (Sweden)
9.11.1 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.11.4 Betagenon AB (Sweden) Business Overview
9.11.5 Betagenon AB (Sweden) Recent Developments
9.12 miRagen Therapeutics, Inc. (US)
9.12.1 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.12.4 miRagen Therapeutics, Inc. (US) Business Overview
9.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
9.13 Multi Gene Vascular Systems Ltd (Israel)
9.13.1 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.13.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
9.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
9.14 ViroMed Co. Ltd. (Korea)
9.14.1 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.14.4 ViroMed Co. Ltd. (Korea) Business Overview
9.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
10 Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast
10.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region
10.2.4 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peripheral Arterial Disease (PAD) Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2030)
11.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2030)
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings